Leukemia Research
Volume 29, Issue 2 , Pages 135-140, February 2005

High Th1/Th2 ratio in patients with multiple myeloma

  • Hatsue Ogawara

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Hiroshi Handa

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Tohru Yamazaki

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Takuma Toda

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Kensuke Yoshida

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Natsumi Nishimoto

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Wedad Hamdi Saleh Al-ma’Quol

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
  • ,
  • Yoriaki Kaneko

      Affiliations

    • Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
  • ,
  • Takafumi Matsushima

      Affiliations

    • Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
  • ,
  • Norifumi Tsukamoto

      Affiliations

    • Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
  • ,
  • Yoshihisa Nojima

      Affiliations

    • Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
  • ,
  • Morio Matsumoto

      Affiliations

    • Department of Internal Medicine, National Nishi-Gunma Hospital, Gunma, Japan
  • ,
  • Morio Sawamura

      Affiliations

    • Department of Internal Medicine, National Nishi-Gunma Hospital, Gunma, Japan
  • ,
  • Hirokazu Murakami

      Affiliations

    • Department of Laboratory Sciences, School of Health Sciences, Faculty of Medicine, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan
    • Corresponding Author InformationCorresponding author.

Received 19 March 2004; accepted 5 June 2004.

Abstract 

To determine the clinical significance of the T helper 1(Th1)/T helper 2 (Th2) ratio in multiple myeloma, the intracellular IFN-γ and IL-4 were analyzed by flow cytometry in 56 patients with multiple myeloma. The mean Th1/Th2 ratio of cases in the initial diagnosis phase and the refractory phase were higher than that of the control group. The mean serum beta-2-microglobulin in the high Th1/Th2 subgroup was significantly higher than that in the normal Th1/Th2 subgroup (P < 0.05). In conclusion, the Th1/Th2 ratio was closely related to the disease status of multiple myeloma.

Keywords: Myeloma, T cell, Th1, Th2, Immunoglobulin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(04)00227-9

doi:10.1016/j.leukres.2004.06.003

Leukemia Research
Volume 29, Issue 2 , Pages 135-140, February 2005